Immunological memory is characterized by a more rapid and efficient response to previously encountered pathogens. Thereby, memory recall responses protect against infections that can otherwise cause disease or even death in immunologically naive hosts. Memory CD8^+^ T cells (T~M~) are instrumental for the rapid detection and eradication of intracellular pathogens. Several subsets of T~M~ have been identified based on their migration patterns, anatomical location, and functional specialization ([@bib37]). Historically, memory T cells have been divided into central memory T cells (T~CM~) and effector memory T cells (T~EM~; [@bib46]). T~CM~ home to secondary lymphoid organs, exhibit high proliferative capacity upon reencountering cognate antigen, and serve as a self-replenishing pool that gives rise to other memory T cell subsets ([@bib19]). Conversely, T~EM~ do not express the homing receptors characteristic of T~CM~, recirculate through the body, and can provide immediate effector function ([@bib46]). Recently, tissue-resident memory T cells (T~RM~) have been identified as an additional subset of memory T cells that does not recirculate, but persists at sites of previous infection, such as skin and mucosal tissues ([@bib48]; [@bib40]), as well as the brain ([@bib59]). T~RM~ from various organs, including the brain show overlapping transcriptional profiles with a core transcriptional signature ([@bib47]), distinguishing them from circulating T~M~ ([@bib60]; [@bib31]). In most nonlymphoid tissues, T~RM~ outnumber patrolling T~EM~ and constitute the largest component of T cell memory ([@bib58]). Their persistence in organs is mediated by specific adhesion molecules, such as CD103 (Integrin αE; [@bib17]; [@bib11]; [@bib31]) and loss of tissue egress receptors from the cell surface ([@bib54]; [@bib32]). Bona fide T~RM~ have been described to express CD69, which antagonizes the tissue egress receptor sphingosine 1-phosphate receptor 1 (S1P1; [@bib32]). Surface expression of CD103 seems specific for T~RM,~ but not all T~RM~ express the molecule. Long-lived CD103^−^ T~RM~ have been described in secondary lymphoid organs ([@bib51]), in the gut ([@bib7]), and in the female reproductive tract ([@bib58]). CD103 expression has been associated with tissue retention ([@bib59]; [@bib11]; [@bib31]), epithelial localization ([@bib17]; [@bib52]) and function ([@bib59]; [@bib29]; [@bib7]), but it remains elusive whether CD103 expression is causally linked to these characteristics. The generation and maintenance of T~RM~ is dependent on IL-7 and IL-15-mediated signals ([@bib31]; [@bib1]), however, whether T~RM~ undergo homeostatic proliferation to maintain a stable population has so far not been demonstrated.

T~RM~ accelerate and improve pathogen clearance upon reinfection ([@bib17]; [@bib25]; [@bib53]; [@bib60]; [@bib52]), but the underlying mechanisms remain a subject of ongoing investigation. Reactivation of T~RM~ by cognate antigen leads to the production of inflammatory cytokines, such as IFN-γ. Consequently, antiviral genes are induced and additional immune cells are rapidly recruited from the circulation ([@bib49], [@bib50]; [@bib4]). The currently prevailing concept therefore suggests that T~RM~ represent a tissue-restricted surveillance system with the capacity to alert circulating T~M~ in case of reinfection ([@bib10]). Conversely, a potential function of T~RM~ as directly cytotoxic antiviral effectors, and thus as an autonomous immunological barrier to viral reinfection, has so far been mostly dismissed, owing to the small number of T~RM~, which persist after primary infection, although reports suggest a direct antiviral function of skin T~RM~ ([@bib30]; [@bib25]; [@bib33]).

Here, we studied brain T~RM~ (bT~RM~) in established mouse models of viral CNS infection. Antiviral bT~RM~ persisted in the CNS for prolonged periods of time, underwent homeostatic proliferation, and served as a potent cellular barrier of antigen-specific immunity, which achieved virus control independently of circulating T cells. Rapid bT~RM~-mediated virus clearance relied on IFN-γ expression and perforin-mediated cytotoxicity and protected mice from immunopathological CNS disease. Our findings suggest that bT~RM~ can act as an organ-autonomous defense system of the CNS.

RESULTS {#s01}
=======

CD103^+^ and CD103^−^ bT~RM~ persist after cerebral viral infection and accelerate pathogen clearance during infection with a related virus {#s02}
-------------------------------------------------------------------------------------------------------------------------------------------

To study the generation and function of bT~RM~, we infected mice intracerebrally (i.c.) with a genetically engineered, attenuated lymphocytic choriomeningitis virus (LCMV) variant (rLCMV; [@bib41]). As previously shown ([@bib42]), i.c. administered rLCMV rapidly drained to the periphery and triggered a potent peripheral antiviral CD8^+^ T cell response, which resolved the brain infection within ten days ([Fig. 1 A](#fig1){ref-type="fig"}). Thereafter, T cell numbers in the brain contracted, but a population of T~M~ persisted in stable number and frequency from 6 wk after infection onwards ([Fig. 1, B and C](#fig1){ref-type="fig"}). At that time point, most persisting T~M~ cells expressed CD69, a prototypic T~RM~ marker. CD69^+^ brain T~M~ expressed high Bcl-2 levels, and many were Granzyme B--positive (59 ± 3%), whereas most of them were specific for the immunodominant LCMV epitope NP~396-404~ (82 ± 5%). However, only about half of these cells (50 ± 10%) expressed CD103 ([Fig. 1 D](#fig1){ref-type="fig"} and [Fig. S1](http://www.jem.org/cgi/content/full/jem.20151916/DC1){#supp1}). Both CD103^+^ and CD103^−^ CD69^+^ T~M~ subsets persisted in stable relative proportions over time ([Fig. 1 E](#fig1){ref-type="fig"}). Analogously to the endogenous CD8^+^ T cell pool, both CD103^+^ and CD103^−^ brain T~M~ subsets were found in adoptively transferred CD8^+^ TCR transgenic P14 or OT-1 cells, respectively, after i.c. infection with rLCMV variants encoding the respective cells' cognate epitopes ([Fig. 1 F](#fig1){ref-type="fig"}). Furthermore, CD103^+^ and CD103^−^ OT-1 brain T~M~ were generated after intrathecal infection with a modified vaccinia virus (MVA; [@bib45]) expressing OVA ([Fig. 1 G](#fig1){ref-type="fig"}). CD69 expression correlated with exclusion from staining with i.v. administered fluorescent antibody ([@bib2]; [Fig. 1 H](#fig1){ref-type="fig"}) and extravascular CD8^+^ T cells identified by immunostaining on brain sections expressed CD69 (95 ± 3%; *n* = 3 mice). Furthermore, most brain CD69^+^ T~M~ cells were refractory to depletion by peripherally administered depleting anti-CD8 antibody ([Fig. 1 I](#fig1){ref-type="fig"}). Altogether, this demonstrated that the vast majority of CD69^+^ T~M~ cells in brain were bona fide T~RM~ (from now on referred to as bT~RM~).

![**CD103^+^ and CD103^−^ T**~**M**~ **persist in the brain after cerebral viral infection.** (A) Representative brain sections of WT mice immunostained for LCMV nucleoprotein (arrows) at indicated days after rLCMV i.c. infection. Bars: 100 µm; (inset) 20 µm. (B--F) Flow cytometric analysis of brain-derived CD8^+^ T cells after rLCMV i.c. infection (as in Fig. S1). (B) Quantification of brain CD8^+^ T cell numbers and (C) frequencies of T~M~ and short-lived effectors (SLE) at indicated days (d) after infection. (D) CD69^+^ brain T~M~ (bT~M~) were analyzed for surface expression of CD103, binding of D^b^-NP~396-404~-tetramer, and intracellular expression of Bcl-2 and Granzyme B (GzmB; filled histograms, antibody stainings; open histograms, staining controls) 6 wk after infection. Numbers indicate frequencies of positive cells (mean ± SEM; *n* = 3 mice). (E) Frequencies of CD103^+^ bT~M~ at indicated days (d) after infection. (F and G) P14 or OT-1 TCR transgenic CD8^+^ T cells were adoptively transferred into naive WT mice 24 h before infection with indicated viruses. CD69 and CD103 surface expression on the adoptively transferred T cells (CD45.1^+^) and on endogenous MVA-specific CD8^+^ T cells (Kb-B8R~20-27~-Tet^+^) in brains was analyzed by flow cytometry at 14 (F) or 6 wk (G) after infection. The frequencies of cells in the different gates are indicated (mean ± SEM; *n* = 4--5 mice per group). (H) 3 mo after infection with rLCMV i.c., anti--CD8b-PE was injected i.v. and PE-labeled CD8b^+^ T cells were measured in the blood and the brain by flow cytometry. Representative plots of CD8b-positive (intravascular, red) and -negative (extravascular, blue) CD8a^+^ T cells in relation to CD69 expression are shown. The frequencies of cells in the different gates are indicated (mean ± SEM; *n* = 4--5 mice per group). (I) rLCMV i.c. infected WT mice were treated with anti-CD8a depleting antibody i.p. 6 wk after infection. Frequencies and numbers of CD103^+^ and CD103^−^ brain T~M~ (CD8^+^CD44^+^CD69^+^) were analyzed by flow cytometry 6 wk later. (B, E, and I) Bars represent mean + SEM (*n* = 5--6 mice per group). One representative of (A, D, H, and I) or data pooled from (B, C, and E) at least two independent experiments is shown. (F and G) Experiments were performed once. For flow cytometric gating strategy see Fig. S1.](JEM_20151916_Fig1){#fig1}

To investigate the protective role of bT~RM~ upon brain reinfection, we generated rLCMV memory mice by either i.v. or co-infection (i.c. + i.v.; [Fig. 2 A](#fig2){ref-type="fig"}). Co-infection was used to assure similar generation of circulating T~M~. Indeed, both infection routes led to similar frequencies of D^b^-NP~396-404~ LCMV-specific T~M~ in peripheral blood ([Fig. 2 B](#fig2){ref-type="fig"}). However, in contrast to bT~RM~ generated upon i.c. infection, only limited numbers of T~M~ cells were present in the brain after i.v. infection with rLCMV ([Fig. 2, C and D](#fig2){ref-type="fig"}). These latter cells were susceptible to depletion by peripherally administered anti-CD8a antibody (unpublished data) demonstrating that T~M~ detectable in the brain after i.v. rLCMV infection are in equilibrium with the circulation and do not represent bona fide bT~RM~. In addition, brain circulating T~M~ generated by i.v. infection failed to up-regulate CD103 and contained a lower percentage of D^b^-NP~396-404~--specific cells than bT~RM~ generated by i.c. infection ([Fig. 2 E](#fig2){ref-type="fig"}). Next, rLCMV memory mice with bT~RM~ (i.c. + i.v. rLCMV co-infection) or without bT~RM~ (i.v. rLCMV infection) were i.c. challenged with pathogenic WT LCMV (LCMVwt), which shared the immunodominant NP~396-404~ epitope with rLCMV ([Fig. 2 F](#fig2){ref-type="fig"}). When analyzed 3 d later, rLCMV memory mice with bT~RM~ exhibited significantly lower LCMV virus load in the brain than rLCMV memory mice with only circulating T~M~. This indicated that the generation of bT~RM~ provided an advantage during reinfection.

![**Brain T~RM~ generated by local infection are associated with accelerated virus clearance.** (A) WT mice were infected with rLCMV i.v. or co-infected i.v. + i.c., and brains were analyzed at least 6 wk later. (B) Frequencies of D^b^-NP396-404--specific CD8^+^ T cells in peripheral blood. (C) Representative images of immunostained brain sections for CD8^+^ T cells (arrows) and quantification thereof. Bars: 100 µm; (inset) 20 µm. (D) Frequencies of bT~RM~ (CD8^+^CD44^+^CD69^+^) in total brain leukocytes as determined by flow cytometry (as in Fig. S1). (E) Representative flow cytometry plot of CD103 and D^b^-NP396-404-tetramer on brain T~M~ (left) and frequencies of D^b^-NP396-404--specific brain CD8^+^ T cells (CD8^+^CD44^+^CD69^+^; right). Numbers represent frequencies (%) of positive events. (F) WT mice were infected with rLCMV as in A and challenged with LCMVwt i.c. 6 wk later. Naive WT mice infected with LCMVwt i.c. were used as controls. Quantification of LCMV RNA by qPCR in the brain (normalized to the virus load in naive mice infected with LCMVwt i.c. = 1). (B--E) Bars represents mean and each symbol represents an individual mouse (*n* = 3--4 mice per group) or (F) bars represent mean + SEM. (*n* = 5 mice per group). \*\*, P \< 0.01, one-way ANOVA followed by Tukey's multiple comparisons test. One out of at least two independent experiments is shown.](JEM_20151916_Fig2){#fig2}

CD103^+^ and CD103^−^ bT~RM~ persist in proximity to anatomical barriers and undergo homeostatic proliferation {#s03}
--------------------------------------------------------------------------------------------------------------

We next analyzed the spatial distribution of bT~RM~ on brain sections by immunohistochemistry. bT~RM~ were preferentially detected at brain surface structures, such as meninges and choroid plexus, around the ventricles or at anatomical borders between different brain regions ([Fig. 3 A](#fig3){ref-type="fig"}). Only a small fraction of bT~RM~ was in direct contact with vascular endothelium (14 ± 3%; [Fig. 3 A](#fig3){ref-type="fig"}), but most bT~RM~ localized in close proximity to vessels and brain surface structures, or both ([Fig. 3 B](#fig3){ref-type="fig"}). Quantification of CD103^+^ and CD103^−^ bT~RM~ in the analyzed areas did not reveal a correlation of CD103 expression with their localization ([Fig. 3 C](#fig3){ref-type="fig"}). Interestingly, a consistent fraction of bT~RM~ expressed proliferation marker Ki-67 (9 ± 1%) long after virus clearance ([Fig. 3 D](#fig3){ref-type="fig"}). bT~RM~ at brain surface structures expressed Ki-67 more frequently than bT~RM~ localized in brain parenchyma ([Fig. 3 E](#fig3){ref-type="fig"}). Previous studies have shown that IL-7-- and IL-15--dependent longevity and homeostatic proliferation are maintaining central memory T cells by Stat5 signaling ([@bib9]; [@bib61]; [@bib21]). Indeed, a fraction of brain T cells showed Stat5 phosphorylation (26 ± 7%). Similarly to Ki-67^+^ T cells, we observed an increased proportion of P-Stat5^+^ T cells at brain surface structures ([Fig. 3 F](#fig3){ref-type="fig"}). Using histocytometry ([Fig. S2](http://www.jem.org/cgi/content/full/jem.20151916/DC1){#supp2}), we could confirm that meninges contained a higher frequency of P-Stat5^+^ T cells than internal brain structures ([Fig. 3 G](#fig3){ref-type="fig"}). Altogether, this indicates that Stat5-driven homeostatic proliferation contributes to the maintenance of the long-lived bT~RM~ population preferentially at brain surface structures.

![**bT~RM~ are localized in proximity to surface-associated structures and show homeostatic proliferation.** (A--G) Mice were infected with rLCMV i.c. to generate bT~RM~ and analyzed at least 6 wk later. (A) Regional distribution of CD8^+^ T cells within the brain. Representative immunofluorescent images of CD8^+^ cells localized at meninges (M), choroid plexus (CP), periventricular area (PV), interareal borders (B), and parenchyma (P), and quantification of CD8^+^ cell density in these areas are shown. Vessels are visualized by immunostaining for Von-Willebrand Factor (VWF). Dotted lines mark the separation to the brain parenchyma. (B) Density plot of brain CD8^+^ cells in relation to surface structures and vessels. Data are pooled from three mice. (C) Representative images of brain immunofluorescence co-staining for CD8 and CD103 and quantification of CD103^+^ and CD103^−^ CD8^+^ T cells grouped in brain areas as defined in A are shown. Data are pooled from three mice (n = total counted cells). (D) Representative flow cytometry plot of Ki-67--expressing bT~RM~ (CD8^+^CD44^+^CD69^+^; *n* = 4--5 mice per group). (E and F) Representative images of Ki-67-- (E) or P-Stat5--positive and negative (F) T cells (left) and proportion of positive T cells at brain surface structures (meninges, choroid plexus, periventricular areas, interareal borders) in comparison to brain parenchyma (right). \*, P \< 0.05, paired two-tailed Student's *t* test. (G) Histocytometry analysis of P-Stat5--positive T cells in relation to their distance to surface (meninges). Data are pooled from three mice. Numbers represent frequencies (%) of cells in corresponding gates. Bars: (A, E, F, and inset in C) 10 µm; (C) 100 µm. For histocytometry data processing and gating strategy, see Fig. S2.](JEM_20151916_Fig3){#fig3}

bT~RM~ autonomously clear pathogenic LCMV challenge independently of circulating T~M~ cells {#s04}
-------------------------------------------------------------------------------------------

To assess the contribution of circulating CD8^+^ T cells to virus control in the brain, we treated a group of rLCMV memory mice with anti-CD8 depleting antibody before LCMVwt i.c. challenge ([Fig. 4 A](#fig4){ref-type="fig"}). rLCMV memory mice with bT~RM~ and circulating T~M~ contained significantly more T cells in the brain after challenge than mice with only circulating T~M~ ([Fig. 4, B and C](#fig4){ref-type="fig"}). As expected ([@bib49]), the numbers of brain-infiltrating T cells in the former group were significantly reduced when circulating T~M~ were depleted. This indicated that about half of the brain CD8^+^ T cells after LCMVwt challenge of nondepleted mice originated from a recruitment of circulating T~M~, whereas the other half represented bT~RM~ and their progeny. Furthermore, 47 ± 13% of bT~RM~ expressed proliferation marker Ki-67 after LCMVwt i.c. challenge ([Fig. 4 D](#fig4){ref-type="fig"}), indicating that a substantial fraction of bT~RM~ entered the cell cycle upon antigen reencounter in the CNS. During LCMV i.c. challenge, both CD103^+^ and CD103^−^ bT~RM~ expanded in similar proportions and showed equal potential for Ki-67 up-regulation ([Fig. 4, E and F](#fig4){ref-type="fig"}). Intriguingly, rLCMV memory mice with bT~RM~ but lacking circulating T~M~, cleared virus from the brain equally efficiently as mice with both bT~RM~ and circulating T~M~ ([Fig. 4, C, G, and H](#fig4){ref-type="fig"}). This suggested that recruitment of circulating T~M~ was not required for bT~RM~-mediated virus clearance from the brain. Conflicting reports exist about T~RM~ dependency on CD4^+^ T help in different organs ([@bib25]; [@bib29]). To address the role of CD4^+^ T cells for the generation and function of bT~RM~, we depleted CD4^+^ T cells either during primary i.c. infection with rLCMV or performed a combined depletion of circulating CD4^+^ and CD8^+^ T cells during LCMVwt i.c. challenge. bT~RM~ numbers, as well as bT~RM~-mediated rapid virus clearance during LCMVwt i.c. challenge, was not affected in the absence of CD4^+^ T cell help during bT~RM~ generation or challenge with LCMVwt ([Fig. 5, A--L](#fig5){ref-type="fig"}). Furthermore, to exclude that recruited NK cells contribute to virus clearance, we depleted NK cells in addition to circulating T cells during LCMVwt i.c. challenge. However, virus clearance was unimpaired in animals containing bT~RM~ but not circulating T and NK cells ([Fig. 6, A--E](#fig6){ref-type="fig"}), demonstrating that LCMVwt control relied on bT~RM~.

![**bT**~**RM**~ **mediate rapid LCMV clearance independently of circulating T~M~ cell recruitment.** (A) WT mice were infected with rLCMV i.v. (no bT~RM~) or i.v. + i.c. (bT~RM~). At least 6 wk later, mice were treated i.p. with anti-CD8a depleting antibody before LCMVwt i.c. challenge or left unchallenged, and brains were analyzed 3 d later. (B) CD8^+^ T cells quantification on immunostained brain sections in relation to the presence of bT~RM~ (+), circulating CD8 depletion (+) and LCMVwt i.c. challenge (+). (C) Representative images of CD8 (top, arrows) or LCMV (bottom, arrows) on immunostained brain sections. Bars: 100 µm; (inset) 20 µm. (D) Representative flow cytometry plot (left) and frequencies (right) of Ki-67--expressing bT~RM~ (CD8^+^CD44^+^CD69^+^) after LCMVwt i.c. challenge (+) or in unchallenged control mice (--). Numbers represent frequencies of positive cells. (E) Frequencies of CD103-expressing bT~RM~ in LCMVwt i.c. challenged (+) or unchallenged (--) mice as in D. (F) Frequencies of Ki-67--expressing CD103^+^ and CD103^--^ bT~RM~ as in D. (D--F) Each symbol represents an individual mouse and bars indicate mean. (G) Quantification of LCMV^+^ cells by immunohistochemistry on brain sections and (H) LCMV RNA by qPCR (normalized to naive mice infected with LCMVwt i.c. = 1) in the brain of mice as in B. Data represent mean + SEM (*n* = 3--5 mice for unchallenged controls (−); *n* = 5--6 for mice challenged with LCMVwt i.c.) \*, P \< 0.05; \*\*, P \< 0.01, one-way ANOVA followed by Sidak's multiple comparisons test (B, G, and H); unpaired two-tailed Student's *t* test (D). One representative out of at least two independent experiments is shown (B--H).](JEM_20151916_Fig4){#fig4}

![**bT~RM~ generation and functionality in the absence of CD4^+^ T cell help.** (A) WT mice were infected with rLCMV i.c. 11 wk later, mice were treated with anti-CD8a alone or in combination with anti-CD4 depleting antibody i.p., and subsequently challenged with LCMVwt i.c. Naive WT mice infected with LCMVwt i.c. were used as controls. Brains were analyzed 3 d later. (B) Representative images of brain sections immunostained for CD8 (top, arrows) or LCMV (bottom). Quantification of CD8^+^ T cells (C), LCMV^+^ cells by immunohistochemistry (D), or LCMV RNA by qPCR (E; normalized to naive mice infected with LCMVwt i.c. = 1). (F) WT mice were treated with anti-CD4 depleting antibody as indicated and were infected with rLCMV i.c. 6 wk later, rLCMV memory mice containing helped or unhelped bT~RM~ were treated with anti-CD8a depleting antibody and challenged with LCMVwt i.c. (G) numbers of bT~RM~ (CD8^+^CD44^+^CD69^+^) and (H) frequencies of T~M~ cells (CD127^+^KLRG1^--^) among bT~RM~ (CD8^+^CD44^+^CD69^+^) were determined by flow cytometry in unchallenged rLCMV memory mice. (I--L) 6 wk after antibody-mediated depletion of CD4^+^ T cells, rLCMV memory mice, as in F, were challenged with LCMVwt i.c. and analyzed 3 d later. (I) Quantification of CD8^+^ T cells by immunohistochemistry. (J) Representative images of brain sections immunostained for CD8 (top, arrows) or LCMV (bottom). (G--I) Each symbol represents an individual mouse and bars indicate mean. Quantification of (K) LCMV^+^ cells by immunohistochemistry (L) LCMV RNA by qPCR (normalized to naive mice infected with LCMVwt i.c. = 1) 3 d after LCMVwt i.c. challenge. Data represent mean + SEM (where included). (B--E) *n* = 5 mice per group, (G--H) *n* = 4 mice per group, (I--L) *n* = 3 mice for naive WT mice infected with LCMVwt i.c. (white bars), *n* = 5--6 mice per group of rLCMV memory mice after LCMVwt i.c. challenge. \*, P \< 0.05; \*\*, P \< 0.01, one-way ANOVA with Tukey's multiple comparison test. One experiment was performed. Bars: 100 µm; (inset) 20 µm.](JEM_20151916_Fig5){#fig5}

![**bT~RM~-mediated rapid viral clearance is independent of circulating NK cells.** (A) WT mice were infected with rLCMV i.c. 12 wk later, mice were treated with anti-CD8a only or in combination with anti-NK1.1 depleting antibody i.p., and subsequently challenged with LCMVwt i.c. Naive WT mice infected with LCMVwt i.c. were used as controls. Brains were analyzed 3 d after i.c. challenge. (B) Representative images of brain sections immunostained for CD8 (top, arrows) or LCMV (bottom). Bars: 100 µm; (inset) 20 µm. Quantification of CD8^+^ T cells (C), LCMV^+^ cells (D), or LCMV RNA by qPCR (E; normalized to naive mice infected with LCMVwt i.c. = 1). Data represent mean + SEM (*n* = 5 mice per group). \*\*, P \< 0.01, one-way ANOVA with Tukey's multiple comparison test. One experiment was performed.](JEM_20151916_Fig6){#fig6}

bT~RM~-mediated virus clearance is dependent on presentation of cognate antigen {#s05}
-------------------------------------------------------------------------------

Next, we aimed to investigate if presentation of cognate antigen is necessary or if bystander activation and expression of antiviral genes in surrounding tissue is sufficient for bT~RM~-mediated viral clearance. Therefore, we challenged rLCMV memory mice with a genetically engineered LCMV variant (LCMV-NP~N400S~), in which the MHC-I anchor residue of the immunodominant epitope NP~396-404~ was mutated to abrogate MHC binding ([@bib26]; [Fig. 7 A](#fig7){ref-type="fig"}), thus preventing MHC-I--restricted recognition of this virus by the vast majority of bT~RM~ ([Fig. 1 D](#fig1){ref-type="fig"} and [Fig. 2 E](#fig2){ref-type="fig"}). Accordingly, bT~RM~ expansion was reduced when LCMV-NP~N400S~ was used for challenge instead of LCMVwt ([Fig. 7, B and C](#fig7){ref-type="fig"}). In further contrast to LCMVwt i.c. challenge, bT~RM~ failed to clear the brain from LCMV-NP~N400S~ within 3 d. This was evident in increased numbers of infected cells ([Fig. 7, B and D](#fig7){ref-type="fig"}) and heightened LCMV RNA loads ([Fig. 7 E](#fig7){ref-type="fig"}). Interestingly, antiviral interferon-induced transmembrane protein 3 (Ifitm3), a marker of T~RM~-induced antiviral state ([@bib4]), was similarly induced after infection with LCMVwt or LCMV-NP~N400S~, respectively ([Fig. 7 F](#fig7){ref-type="fig"}). Furthermore, infection with either of the two viruses induced up-regulation of Granzyme B ([Fig. 7, G--H](#fig7){ref-type="fig"}), as well as Ki-67 expression ([Fig. 7, G and I](#fig7){ref-type="fig"}) in bT~RM~. This indicated that the capacity of bT~RM~ to autonomously clear brain virus infection depended on epitope-specific target recognition. Conversely, the virtually uniform activation of bT~RM~ after viral challenge occurred in a largely antigen nonspecific fashion, as D^b^-NP396-404-tetramer^+^ bT~RM~ up-regulated GzmB (96 ± 1%) and Ki-67 (42 ± 3%) during i.c. challenge with LCMV-NP~N400S~ (unpublished data).

![**MHC-I--restricted presentation of cognate antigen is required for bT~RM~-mediated virus clearance.** (A) WT mice were infected with rLCMV i.c. to generate bT~RM~. At least 6 wk later, mice were treated with anti-CD8a depleting antibody i.p. before i.c. challenge with LCMVwt or LCMV-NP~N400S~ or left unchallenged. Brains were analyzed 3 d later. (B) Representative images of CD8 (top, arrows) or LCMV (bottom) on brain sections of virus challenged or unchallenged (−) mice. Bars: 100 µm; (inset) 20 µm. Quantification of CD8^+^ T cells (C), LCMV^+^ cells (D), or LCMV RNA by qPCR (E; normalized to naive mice infected with LCMV i.c. = 1). (F) Quantification of *Ifitm3* mRNA by qPCR in the brain of mice in relation to the presence of bT~RM~ (+) and LCMVwt or LCMV-NP~N400S~ i.c. infection (+; normalized to uninfected mice = 1). (G) Representative flow cytometry plot of GzmB and Ki-67--expressing bT~RM~ (CD8^+^CD44^+^CD69^+^). Numbers represent frequencies of positive cells. Frequencies of (H) GzmB and (I) Ki-67--expressing bT~RM~. (H and I) Each symbol represents an individual mouse. Data represent mean + SEM (*n* = 3--5 mice per group). \*, P \< 0.05; \*\*, P \< 0.01, one-way ANOVA followed by Tukey's (C, D, E, H, and I) or Dunnet's multiple comparison test (F). One representative out of two independent experiments is shown (B--I).](JEM_20151916_Fig7){#fig7}

bT~RM~-mediated rapid viral clearance depends on IFN-γ and perforin {#s06}
-------------------------------------------------------------------

T cell--mediated viral clearance from the brain can be achieved by cytolytic, i.e., perforin or Fas-dependent mechanisms, as well as by noncytolytic, cytokine-dependent pathways ([@bib20]; [@bib42]; [@bib22]). To investigate cytokine production and cytotoxic potential of bT~RM~, we depleted memory mice of circulating CD8^+^ T cells and challenged them with LCMVwt i.c. ([Fig. 8 A](#fig8){ref-type="fig"}). We analyzed CD107a surface exposure as indicator of degranulation of cytotoxic granule release and production of IL-2, IFN-γ, and TNF upon in vitro peptide stimulation ([Fig. 8 B](#fig8){ref-type="fig"} and not depicted). In the absence of LCMVwt challenge and without peptide restimulation, bT~RM~ did not spontaneously produce detectable amounts of cytokines and did not degranulate. After LCMVwt i.c. challenge, bT~RM~ exhibitedIFN-γ production (9.7 ± 1.5%) and surface exposure of CD107a (9.0 ± 0.5%) in the absence of further ex vivo stimulation. After peptide stimulation, most bT~RM~ produced high amounts of IFN-γ in combination with surface exposure of CD107a, which was significantly higher in bT~RM~ from LCMVwt i.c. challenged animals (59.0 ± 2.4%) than from unchallenged controls (36.4 ± 3.1%; [Fig. 8 B](#fig8){ref-type="fig"}). In contrast, we detected comparably few bT~RM~ that coproduced IL-2 or TNF, and we failed to detect expression of FasL on bT~RM~ (unpublished data). Thus our analysis identified IFN-γ--producing bT~RM~ with cytotoxic granule release as main effector cell population after LCMVwt i.c. challenge.

![**bT**~**RM**~**-mediated rapid virus clearance depends on IFN-γ and perforin.** (A) Mice were infected with rLCMV i.c to generate bT~RM~. At least 6 wk later, mice were treated with anti-CD8a depleting antibody i.p. before LCMVwt i.c. challenge or left unchallenged. Brains were analyzed 3 d later. (B, left) Representative flow cytometry plot of IFN-γ production and degranulation as measured by surface exposure of CD107a in bT~RM~ (CD8^+^CD44^+^CD69^+^) of unchallenged (bT~RM~) or LCMVwt i.c.-challenged (bT~RM~ + LCMVwt i.c.) WT mice with (+) or without (--) in vitro NP~396-404~ peptide stimulation. Numbers indicate frequencies (%) of cells in corresponding gates. (right) Frequencies (mean + SEM) of IFN-γ--positive (black bars), CD107a positive (gray bars), and double-positive (blue bars) bT~RM~ with (+) or without (--) LCMVwt i.c. challenge and with (+) or without (--) in vitro NP~396-404~ peptide stimulation (*n* = 3--4 mice per group). (C--G) IFN-γ--competent (control)- or GKO-rLCMV memory mice were generated and treated as in A. (C) Frequencies of T~M~ cells (CD127^+^KLRG1^--^) among bT~RM~ (CD8^+^CD44^+^CD69^+^) as determined by flow cytometry in unchallenged IFN-γ--competent (control) and GKO mice. Each symbol represents an individual mouse and bars indicate mean (*n* = 4 mice per group). (D) Representative images of immunostained brain sections for CD8 (top, arrows) or LCMV (bottom). (E) Quantification of CD8^+^ T cells, (F) LCMV^+^ cells, or (G) LCMV RNA by qPCR (normalized to naive mice infected with LCMVwt i.c. = 1) in brains of GKO and control mice with (+) or without (--) LCMVwt i.c. challenge. Data represent mean + SEM (*n* = 3--10 mice per group). (H--M) Perforin-competent (control)- or PKO-rLCMV memory mice were generated and treated as in A. (H) Frequencies of T~M~ cells among bT~RM~ (as in C) in unchallenged perforin-competent (control) and PKO mice. Each symbol represents an individual mouse and bars indicate mean (*n* = 4 mice per group). (I) Frequencies of GzmB-expressing cells among bT~RM~ as determined by flow cytometry 3 d after LCMVwt i.c. challenge of control or PKO mice. Each symbol represents an individual mouse, and bars indicate mean (*n* = 4--6 mice per group). (J) Representative images of immunostained brain sections for CD8 (top, arrows) or LCMV (bottom). (K) Quantification of CD8^+^ T cells, (L) LCMV^+^ cells, or (M) LCMV RNA by qPCR (normalized to naive mice infected with LCMVwt i.c. = 1) in brains of PKO and control mice with (+) or without (--) LCMVwt i.c. challenge. Data represent mean + SEM (*n* = 4--6 mice per group). \*, P \< 0.05; \*\*, P \< 0.01, asterisk colors represent multiple comparisons performed, two-way ANOVA with Tukey's multiple comparisons (B), one way ANOVA with Sidak's multiple comparisons test (I), unpaired two-tailed Student's *t* test (C, F, G, H, L, and M). One representative (B--F and J--M) or pool (G) of two independent experiments is shown. (H and I) Experiments were performed once. Bars, 100 µm; (inset) 20 µm.](JEM_20151916_Fig8){#fig8}

Considering IFN-γ as the main effector cytokine expressed by bT~RM~, we next tested bT~RM~ function in IFN-γ knockout (GKO) mice. Of note, IFN-γ is dispensable for the clearance of primary infection with attenuated rLCMV ([@bib42]) and bT~RM~ generation was not impaired in GKO mice ([Fig. 8 C](#fig8){ref-type="fig"}). We depleted circulating CD8^+^ T cells in IFN-γ--deficient (GKO) and IFN-γ competent (control) rLCMV memory mice and subsequently challenged them with LCMVwt i.c. ([Fig. 8, D--G](#fig8){ref-type="fig"}). Before LCMVwt i.c. challenge, GKO rLCMV memory mice displayed slightly higher bT~RM~ numbers, but the fold expansion of bT~RM~ after virus challenge was similar in GKO and control animals ([Fig. 8, D and E](#fig8){ref-type="fig"}). This indicated that the cell-intrinsic reactivation capacity of bT~RM~ was unimpaired in GKO mice. Conversely, the number of infected cells ([Fig. 8, D and F](#fig8){ref-type="fig"}) and LCMV RNA loads ([Fig. 8 G](#fig8){ref-type="fig"}) 3 d after LCMVwt i.c. challenge were significantly higher in GKO memory mice than in control memory mice.

Based on the notion that bT~RM~ up-regulated the cytotoxic effector molecule Granzyme B after LCMV i.c. challenge ([Fig. 7, G and H](#fig7){ref-type="fig"}), we next investigated whether cytolytic effector functions ([@bib27]) contributed to bT~RM~-mediated virus clearance. We thus generated perforin-deficient (PKO) rLCMV memory mice and depleted circulating CD8^+^ T cells ([Fig. 8, H--M](#fig8){ref-type="fig"}), as before ([Fig. 8 A](#fig8){ref-type="fig"}). Perforin was dispensable for the generation of bT~RM~ ([Fig. 8 H](#fig8){ref-type="fig"}). Furthermore, after LCMVwt i.c. challenge, perforin-deficient bT~RM~ showed unimpaired up-regulation of Granzyme B ([Fig. 8 I](#fig8){ref-type="fig"}) and secondary expansion ([Fig. 8, J and K](#fig8){ref-type="fig"}). Nevertheless, PKO memory mice exhibited significantly higher numbers of infected cells ([Fig. 8, J and L](#fig8){ref-type="fig"}) and increased viral RNA loads ([Fig. 8 M](#fig8){ref-type="fig"}) than control memory mice. This demonstrated that bT~RM~ cells exert rapid IFN-γ production and perforin-dependent cytotoxicity, both of which made essential contributions to the rapid control of viral infection in the brain.

bT~RM~ cells protect from fatal immunopathological CNS disease in an antigen-dependent manner {#s07}
---------------------------------------------------------------------------------------------

i.c. infection of naive immunocompetent mice with LCMVwt results in fatal choriomeningitis, which is the result of antiviral CD8^+^ T cell--mediated immunopathology ([@bib12]). T~RM~ have been shown to amplify immune responses in nonlymphoid tissues during rechallenge with cognate antigen ([@bib49], [@bib50]). Here, we observed analogous findings in the brain ([Fig. 4 B](#fig4){ref-type="fig"}), raising the possibility that bT~RM~ could enhance immunopathological consequences of brain virus infection ([@bib39]). We therefore investigated how the presence of bT~RM~ impacts the disease after LCMVwt i.c. challenge. For that, we depleted LCMV-specific circulating T~M~ in rLCMV memory mice using anti-CD8 antibody 6 wk before LCMVwt i.c. challenge ([Fig. 9 A](#fig9){ref-type="fig"}). This timing enabled the reconstitution of the peripheral compartment with naive CD8^+^ T cells before LCMVwt challenge (unpublished data). Analogous to the experiment in which anti-CD8 depletion and challenge had been performed simultaneously ([Fig. 4, B and D](#fig4){ref-type="fig"}), the presence of bT~RM~ resulted in enhanced T cell numbers in the brain when circulating memory CD8^+^ T cells were present ([Fig. 9, B and C](#fig9){ref-type="fig"}). However, irrespective of the presence or absence of circulating memory CD8^+^ T cells, brain LCMV loads as assessed 3 d after LCMVwt i.c. challenge were significantly reduced in mice with bT~RM~ compared with mice with only circulating T~M~ ([Fig. 9, B, D, and E](#fig9){ref-type="fig"}). As expected ([@bib39]), mice with only circulating T~M~ did not develop disease, demonstrating that the observed peripheral virus-specific T~M~ recall response can afford antiviral protection ([Fig. 9 F](#fig9){ref-type="fig"}). Furthermore, circulating T~M~-depleted rLCMV memory mice without bT~RM~ developed fatal choriomenigitis, which had kinetics comparable to unimmunized control mice. Most importantly, six out of seven rLCMV memory mice with bT~RM~ were protected from disease even though circulating T~M~ cells had been depleted. This underscored the self-sufficient nature of bT~RM~-mediated antiviral protection. Next, we investigated whether bystander activation of bT~RM~ ([Fig. 7](#fig7){ref-type="fig"}) was sufficient to protect animals from fatal immunopathology. We therefore depleted rLCMV memory mice of circulating T~M~ and challenged them with either LCMVwt or LCMV-NP~N400S~ i.c. after reconstitution of circulating CD8^+^ T cells. As expected, mice challenged with LCMV-NP~N400S~ i.c. did not mount a D^b^-NP~396-404~--specific CD8^+^ T cell response, but developed a CD8^+^ T cell response specific for the D^b^-GP~33-41~ epitope (data not shown), to which they had not been previously exposed (rLCMV does not encode for LCMV-GP~33-41~). Unlike rLCMV memory mice challenged with LCMVwt i.c., challenge with LCMV-NP~N400S~ i.c. resulted in the development of fatal choriomeningitis with disease kinetics comparable to unimmunized control mice ([Fig. 9 G](#fig9){ref-type="fig"}). Altogether, this demonstrated that bT~RM~ immunity was antigen-specific and provided rapid autonomous elimination of virus-infected cells from the brain and thereby protected from fatal immunopathological disease.

![**bT~RM~ protect against LCMV-induced choriomeningitis in an antigen-dependent manner.** (A) WT mice were infected with rLCMV i.v. (no bT~RM~) or i.v. + i.c. (bT~RM~). At least 6 wk later, mice were treated with anti-CD8a-depleting antibody i.p. followed by 6 wk reconstitution of naive CD8^+^ T cells. Subsequently mice were challenged with LCMVwt or LCMV-NP~N400S~ i.c. (B) Representative images of CD8 (top, arrows) or LCMV (bottom, arrow) on brain sections 3 d after LCMVwt i.c. challenge. Bars: 100 µm; (inset) 20 µm. (C) Quantification of CD8^+^ T cells and (D) LCMV^+^ cells of mice as in C. Each symbol represents an individual mouse and bars indicate mean (*n* = 3--4 mice per group). (E) LCMV RNA by qPCR (normalized to naive mice infected with LCMV i.c. = 1) of mice as in C. Data represent mean + SEM (*n* = 3--4 mice per group). (F) Incidence of fatal choriomenigitis after LCMVwt i.c. challenge (*n* = 7--8 mice per group). (G) Incidence of disease after LCMVwt or LCMV-NP~N400S~ i.c. challenge (*n* = 5 mice per group). \*, P \< 0.05; \*\*, P \< 0.01, (C--E) one-way ANOVA with Sidak's multiple comparisons test, (F and G) Log rank Mantel-Cox test. (C, D, E, and G) Experiments were performed once. (F) Data are pooled from two independent experiments.](JEM_20151916_Fig9){#fig9}

DISCUSSION {#s08}
==========

The identification of T~RM~ as a separate lineage of long-lived memory T cells has fundamentally reshaped our concepts of cell-mediated immunity to infection. With this study, we establish bT~RM~ as an autonomous first line of adaptive immune defense against viral infection of the brain. bT~RM~ were found after acute infection with rLCMV or a replication-deficient modified vaccinia virus strain in mice, attesting to the general validity of our findings. bT~RM~ showed strong proliferative potential and protected against fatal viral infection in an organ-autonomous manner, independent of the recruitment of circulating CD8^+^ memory T cells.

Similar to other nonlymphoid organs ([@bib58]), CD69^+^ bT~RM~ represented 90% of CD8^+^ T cells in the brain. Contrary to brain infection with vesicular stomatitis virus ([@bib59]), we found in two independent models that CD103 was expressed only on a proportion of bT~RM~. This may be a result of differences in isolation and quantification methods, as has been described for other organs ([@bib58]). We do not exclude the possibility that CD103^+^ and CD103^−^ bT~RM~ may be functionally different; however both subsets persisted in stable proportions over time, exhibited an analogous preference for retention at surface-lining structures of the brain, and showed equal proliferative capacity upon reactivation. Although bT~RM~ show very limited survival and proliferative capacity in vitro ([@bib59]), they seem to possess self-renewing capacity in vivo and exhibit high proliferative capacity after reactivation. Similar to central memory T cells ([@bib9]; [@bib61]; [@bib21]), the population of long-lived bT~RM~ seems to be maintained by Stat5-driven homeostatic proliferation, preferentially at brain surface structures, such as meninges and periventricular areas. However, the exact nature of a supposed T~RM~ maintaining microenvironment near tissue surfaces that was also observed in other organs, i.e., in the skin ([@bib17]), remains to be investigated.

In naive hosts, the task of rapidly detecting invading pathogens and alerting the adaptive immune defense generally falls to the innate immune system ([@bib24]). The resulting secretion of antiviral effector cytokines, such as type I interferons, is crucial to limiting virus spread until adaptive immune responses are induced and can accomplish viral clearance ([@bib36]). T~RM~ from peripheral organs other than the brain have been described to subserve a similar immunological function, i.e., to alert circulating T cell subsets to invading pathogens and to induce antiviral genes in the tissue surrounding the site of initial infection ([@bib4]; [@bib50]). These functions were reported to be largely dependent on inflammatory cytokines, such as IFN-γ. Similar to T~RM~ from other organs, we show here that bT~RM~ share the capacity to secrete IFN-γ upon antigen reencounter. However, they largely do that in combination with the release of cytotoxic granules, and perforin-mediated cytotoxicity was essential for rapid bT~RM~-mediated virus control. One may thus speculate that IFN-γ--deficient bT~RM~ fail to provide sufficient noncytolytic antiviral function, or fail to prepare the site of infection for lytic effector function as a result of impaired up-regulation of MHC I expression on infected cells ([@bib6]). Whereas both possibilities are not mutually exclusive and can contribute to the observed outcome, our data strongly suggest that a direct interaction of bT~RM~ with infected cells rather than a generalized antiinflammatory state is necessary for bT~RM~-mediated rapid viral elimination. This conclusion is based on our observation that bT~RM~ can be activated in a bystander manner, i.e., in the absence of cognate antigen and solely as the result of the inflammatory environment ([@bib28]; [@bib55]; [@bib44]), yet under such circumstances fail to rapidly control the virus. This does not, however, exclude the possibility that bystander activation may contribute to a viral load reduction in the brain. Furthermore, depending on the pathogen type and infection scenario, bT~RM~-driven induction of IFN-γ response genes may be sufficient to limit early pathogen spread or even to cleanse viruses from nonrenewable cells such as neurons ([@bib20]; [@bib22]).

Neurotropic viruses of hematogenous origin frequently infect the CNS secondary to systemic infection. Neuroinvasion typically occurs through the brains outer or inner linings ([@bib35]), namely the meninges or the ependyma, to subsequently spread into the brain parenchyma. The resulting inflammation manifests as meningitis or even encephalitis and can be life-threatening ([@bib18]). Our model of intracranial rLCMV immunization recapitulates the spread from the brain linings into the parenchyma albeit it does not reproduce neuroinvasion secondary to systemic infection. Conversely, its attenuated behavior enabled us to study solid bT~RM~ immunity without the caveats of life-threatening complications from primary brain infection.

Although we noted a protective function of bT~RM~ in infection, T~RM~--mediated activation and recruitment of inflammatory cells to the site of infection can, however, also have detrimental effects such as those described in the context of skin contact hypersensitivity ([@bib15]). In organs with limited regenerative capacity, such as the CNS, excessive inflammation can induce collateral damage (immunopathology). In this regard, severe immunopathological disease is one of the most dangerous complications of viral infections in the brain, and depending on pathogen loads, circulating T~M~ can even accentuate disease rather than prevent it ([@bib39]). Therefore, not only infections of the CNS but also the resulting immune responses must be tightly controlled. The functioning of bT~RM~ as a border patrol, which rapidly detects and autonomously eliminates the first few virus-infected cells, thus bypasses the need for antigen drainage to lymph nodes and reactivation of T~M~ cells inside secondary lymphoid organs. It has been shown for other organs that T~RM~ cells use a continuous migratory behavior, enabling few cells to survey large organ structures and readily detect their cognate antigen ([@bib3]). The positioning and preferential maintenance of bT~RM~ at surface-associated brain structures and in proximity to vessels as described in this study therefore matches the specific immunological challenge and need of the brain to limit viral spread from the circulation and brain linings into the parenchyma and to rapidly eliminate the initially infected cells. Thereby, bT~RM~ can balance pathogen control against excessive inflammation.

Based on the present observations, we propose to adapt the concept of immunological privilege of the brain. With identification of the bT~RM~ compartment, the brain undoubtedly maintains powerful immunological forces to fight recurrent microbial intruders. This observation stands in stark contrast to the several layers of immunomodulatory mechanisms, including constitutively low expression of MHC molecules ([@bib38]), which are in place to limit inflammation in the brain ([@bib16]). Thus, pathogens that have previously invaded the brain appear to be specifically excluded from this immunological privilege and are instead rapidly and efficiently eliminated by bT~RM~. It is tempting to speculate that bT~RM~ immunity must be particularly potent because the blood--brain barrier prevents antibody access to the brain, and thus is largely excluding this organ from protection by the humoral arm of immunological memory.

MATERIALS AND METHODS {#s09}
=====================

 {#s10}

### Mice {#s11}

C57BL/6 WT, IFN-γ deficient (GKO; [@bib13]), perforin-deficient (PKO; [@bib27]), OT-1 TCR transgenic ([@bib23]), and P14 TCR ([@bib43]) transgenic mice were bred and lodged under P2 conditions in the animal facilities of the University Medical Centre of Geneva and Munich. Sex- and age-matched mice between 6 and 12 wk of age were used for experiments. All animal experiments were authorized by the cantonal veterinary office of Geneva and performed in agreement with the Swiss law for animal protection.

### Virus infection {#s12}

Recombinant LCMV strains were generated according to established methods ([@bib41]). The following virus strains were used: recombinant LCMV encoding for the glycoprotein of vesicular stomatitis virus (VSV) instead of its own glycoprotein (rLCMV/INDG, abbreviated rLCMV throughout); rLCMV encoding for a chimeric glycoprotein of VSV containing the leader sequence of LCMV glycoprotein with the GP33 epitope of LCMV (rLCMV-GP33); and recombinant LCMV encoding for OVA (rLCMV-OVA). Genetically engineered WT LCMV (LCMVwt, Armstrong strain) and LCMV mutant virus (LCMV-NP~N400S~) lacking the CTL-specific epitope NP~396-404~ were generated as described previously ([@bib26]). Viruses were produced, titrated, and administered to mice as previously described ([@bib14]). For transient virus infection in the brain, 10^4^ PFU rLCMV was administered i.c. i.v. infected control animals were injected i.c. with vehicle. Memory and naive mice were challenged with 10^3^ PFU LCMVwt (Armstrong strain) i.c. Incidence of choriomenigitis was determined by occurrence of general malaise and hind limb cramps, and severely diseased animals were immediately sacrificed. Brain virus load was analyzed by quantitative RT-PCR for LCMV-NP ([@bib34]). Brain total RNA was isolated from deparaffinized tissue sections using RNeasy Mini kit (QIAGEN), cDNA was synthesized using iScript cDNA synthesis kit (Bio-Rad Laboratories), and relative expression of LCMV S segment was determined against GAPDH as housekeeping gene (QIAGEN) using iQ SYBR Green Supermix (Bio-Rad Laboratories).

Replication-deficient MVA-OVA was generated as described previously ([@bib56]). 2 × 10^6^ IU MVA-OVA was administered intrathecally (i.th.) as previously described ([@bib45]). In some experiments, OT-1 or P14 TCR transgenic CD8^+^ T cells were adoptively transferred into naive C57BL/6 mice 24 h before i.c. or i.th. infection.

### Antibody-mediated depletion {#s13}

For depletion of peripheral CD4^+^ T cells, CD8^+^ T cells, or NK cells, mice were treated i.p. twice over a 3-d interval with 250 µg anti-CD4 antibody (YTS191), 450 µg anti-CD8a depleting antibody (clone YTS169.4), or 500 µg anti-NK1.1 depleting antibody (clone PK136), respectively. Depletion of T cells or NK cells was confirmed by flow cytometry showing T cell or NK cell frequencies \<0.1% during LCMVwt i.c. challenge. After antibody-mediated CD8^+^ T cell depletion and subsequent reconstitution by naive CD8^+^ T cells, frequencies of D^b^-NP~396-404~--specific CD8^+^ T cells in rLCMV memory mice were reduced from 1.4 ± 0.3% to 0.06 ± 0.02%, which was not significantly above technical background in uninfected naive control mice (0.005 ± 0.004%).

### Intravascular staining of CD8^+^ T cells {#s14}

Mice were injected i.v. with 3 µg PE-labeled anti-CD8b (YTS156.7.7) according to previously described protocols ([@bib2]). 3 min later, peripheral blood samples were taken, and mice were anesthetized and perfused with PBS. Brains were dissected and processed immediately (\<10 min after antibody injection) for leukocyte isolation (see Flow cytometry).

### Immunohistochemistry {#s15}

For immunohistochemical bright field staining of mouse tissue, brains and spleen were prepared and fixed in Hepes-glutamic acid buffer-mediated organic solvent protection effect (HOPE, DCS Innovative) fixative as previously described ([@bib8]) and embedded in paraffin. Upon inactivation of endogenous peroxidases, tissue sections were incubated with rat anti--mouse CD8a (YTS169.4) or rat anti-LCMV NP (VL-4; [@bib5]). Bound primary antibodies were visualized with biotin-labeled anti--rat antibody and streptavidin-peroxidase staining method using polymerized 3,3′-diaminobenzidine (all reagents from Dako; haemalaun counterstaining of nuclei).

For immunofluorescence staining of mouse tissue, cryosections were fixed with 2% PFA for 5 min and unspecific binding blocked (PBS/1% BSA/2% FCS). Sections were incubated with FITC-labeled Armenian hamster anti--mouse CD103 (2E7) and rat anti--mouse CD8a (YTS169.4), followed by rabbit anti-FITC (Invitrogen) antibody. Bound antibodies were visualized with Alexa Fluor 488--labeled goat anti--rabbit and Cy3-labeled goat anti--rat secondary antibodies (Jackson ImmunoResearch Laboratories). Nuclei were stained with DAPI (Invitrogen).

For immunofluorescence staining of paraffin embedded tissue, mice were transcardially perfused with 4% PFA. After antigen retrieval and unspecific binding blocking (PBS/10% FCS), sections were incubated with rat anti--human CD3 (CD3-12), rat anti--mouse CD8 (clone 4SM15), goat anti--mouse CD69 (AF2386), rabbit anti-VWF (ab6994), rabbit anti--Ki-67 (ab66155), and rabbit anti--phospho-Stat5 (tyr694, C71E5). Bound antibodies were visualized with Alexa Fluor 488 or Alexa Fluor 568 goat anti--rabbit tyramide signal (TSA) amplification (Thermo Fisher Scientific), Cy2- or Cy3-labeled goat-anti--rat, or Cy5-labeled goat anti--rabbit secondary antibodies (Jackson ImmunoResearch Laboratories). Nuclei were stained with DAPI (Invitrogen).

Immunostained sections were scanned using Pannoramic Digital Slide Scanner 250 FLASH II (3DHISTECH) in 200× magnification. Quantifications were performed manually using Pannoramic Viewer software (3DHISTECH) blinded to the experimental setup of histological samples. For representative images, white balance was adjusted and contrast was linearly enhanced using the tools levels, curves, brightness, and contrast in Photoshop CS6 (Adobe). For histocytometry analysis, fluorescence-immunostained brain sections were scanned using a high-dynamic range camera (16 bit).

For histocytometry and density plots, CD3^+^ or CD8^+^ cells, respectively, were detected on scanned slides applying a custom-programmed script in Cognition Network Language (Definiens Developer XD software). For analysis of distance, a grayscale distance map was computed to encode the closest distance of each detected CD3^+^ or CD8^+^ cell to the brain surface and vessels (detected by von-Willebrand Factor staining) and mean values of distance maps were extracted. For histocytometry, each CD3^+^ cell size (area), as well as mean and max grayscale values for CD3, P-Stat5, and DAPI signals, were extracted. The resulting CSV files were converted to .fcs format using an open source program (FlowJo). The converted file was analyzed using FlowJo X. Co-staining of anti-CD3 and anti--phospho-Stat5 was gated based on control staining without primary P-Stat5 antibody.

### Flow cytometry {#s16}

For staining, the following antibodies were used: anti--Bcl-2 (BCL/10C4), anti-CD3e (145-2C11), anti-CD8a (53--6.7), anti-CD11a (M17/4), anti-CD11b (M1/70), anti-CD44 (IM7), anti-CD45.1 (A20), anti-CD45.2 (104), anti-CD45R/B220 (RA3-6B2), anti-CD49a (HMα1), anti-CD49b (DX5), anti-CD49d (9C10), anti-CD69 (H1.2F3), anti-CD103 (2E7), anti-CD107a (1D4B), anti-CD127 (A7R34), anti--E-Cadherin (36/E-Cadherin), anti-FasL (MFL3), anti--Granzyme B (GB11), anti--IFN-γ (XMG1.2), anti--IL-2 (JES6-5H4), anti-Integrinβ7 (FIB27), anti--Ki-67 (SolA15), anti-KLRG1 (2F1), anti-NK1.1 (PK136), and anti-TNF (MP6-XT22). For detection of virus-specific CD8^+^ T cells, D^b^-NP~396-404~-tetramer (TCmetrix) or K^b^-B8R~20-27~-tetramer (provided by D.H. Busch, Institute of Medical Microbiology, Immunology and Hygiene, Technical University Munich, Munich, Germany) were used.

Peripheral blood samples and splenocytes were collected in FACS-Buffer (10% FCS, 10 mM EDTA, and 0.01% NaN~3~ in PBS). Peripheral blood erythrocytes were lysed using BD FACS lysing solution (BD). For the preparation of brain leukocytes, mice were anesthetized and transcardially perfused with PBS. Brains were minced, digested with Collagenase/DNaseI (Roche), and homogenized using 70-µm cell strainers (BD). Leukocytes were separated using a discontinuous Percoll gradient (30%/70%). Surface staining was performed with directly labeled antibodies and tetramers in FACS buffer. Isolated CD8^+^ T cell numbers were quantified using TruCOUNT tubes (BD) or AccuCheck Counting Beads (Invitrogen) as previously described ([@bib57]). Intracellular staining of Ki-67 was performed using FoxP3/Transcription Factor Staining Buffer Set (eBioscience) according to manufacturer's instructions. For ex vivo staining of Granzyme B, cells were fixed and permeabilized using commercial permeabilization buffer set (BioLegend). To assess degranulation and intracellular cytokine production, brain leukocytes were cultured for 5 h in the presence of 5 µg/ml FITC-labeled anti-CD107a antibody, monensin, and brefeldin A. Cells were stimulated in vitro with 1 µM NP~396-404~ peptide or left unstimulated, respectively. Cells were harvested and dead cells were excluded from the analysis using Zombie NIR Fixable Viability kit (BioLegend). Cells were fixed and permeabilized using commercial permeabilization buffer set (BioLegend), followed by intracellular staining for cytokines, respectively. Flow cytometric samples were acquired on a Gallios cytometer (Beckman-Coulter) equipped with three lasers (blue, 488 nm; red, 633 nm; and violet, 405 nm) using appropriate filter sets and compensation controls. Gates were assigned according to appropriate control populations. A CyAn ADP analyzer (Beckman-Coulter) was used for experiments involving MVA-OVA.

### Statistical analysis {#s17}

Analysis was performed using GraphPad 6.0 (Prism). To assess significant differences between single measurements of two groups, unpaired or paired two-tailed Student's *t* test was used, whereas differences between single measurements of more than two groups was assessed by one-way ANOVA, followed by post hoc analyses of selected pairs of datasets using Sidak's multiple comparisons test or all pairs of datasets using Tukey's multiple comparisons test to control for multiple comparisons. To assess significant differences between groups with multiple measurements, two-way repeated-measures ANOVA was performed followed by Dunnet's multiple comparisons test against control group. For comparison of disease incidence, Log rank (Mantel-Cox) test was used. P \< 0.05 was considered significant, and P \< 0.01 was considered highly significant, whereas P \> 0.05 was considered statistically not significant.

### Online supplemental material {#s18}

Fig. S1 shows the gating strategy used for analysis of brain-derived leukocytes. Fig. S2 shows the histocytometry data processing and the gating strategy. Online supplemental material is available at <http://www.jem.org/cgi/content/full/jem.20151916/DC1>.

Supplementary Material
======================

###### Supplemental Materials

We thank Prof. D.H. Busch (Technical University Munich) for providing K^b^/B8R20 tetramers.

D. Merkler holds stipendiary professorships of the Swiss National Science Foundation (No. PP00P3_152928) and is supported by the Klaus-Tschira Foundation, Helmut Horten Foundation, and Gebert-Rüf Foundation. D. Merkler, K. Steinbach, and N. Page are supported by the Swiss MS Society. T. Korn is funded by SyNergy, ERC consolidator grant, DFG SFB 1054, TR 128. I. Drexler is supported by Deutsche Forschungs Gesellschaft GRK 1949.

The authors declare no competing financial interests.

Author contributions: K. Steinbach and I. Vincenti performed the experiments and analyzed the data. M. Kreutzfeldt, N. Page, I. Wagner, and A. Muschaweckh assisted in mouse experiments, data collection, and analysis. D. Pinschewer and T. Korn were involved in study design. I. Drexler provided viral vector. K. Steinbach and D. Merkler designed the studies. K. Steinbach, D. Pinschewer, and D. Merkler wrote and revised the manuscript. All authors discussed results and commented on the manuscript.

Abbreviations used:bT~RM~brain-resident T~RM~GKOIFN-γ knockoutLCMVlymphocytic choriomeningitis virusMVAmodified vaccinia virus AnkaraPKOperforin-knockoutS1P1sphingosine 1-phosphate receptor 1T~RM~tissue-resident memory T cells

[^1]: K. Steinbach and I. Vincenti contributed equally to this paper.
